Skip to main content

Clinical Studies

Clinical Study A: observational cohort

In clinical study A, a group of 150 patients (Group A) will be followed for 12 months in the period February 2024-June 2025 by registering exacerbations and by performing periodic clinical examinations to provide the clinical references for the Artificial intelligence tools.

Data collected by the study A will be exploited to:

Clinical Study B: validation cohort

In the clinical study B, a group of 130 patients (Group B1) will be followed for 12 months in the period September 2025-March 2027 with the set of smart sensors. During study B, the prediction of exacerbations and assessment of health outcomes enabled by the analytics tools will be made available to the clinicians through a software interface to support the clinician decisions for a precise and optimized management of COPD.